Learn more about our active vaccine clinical trials. All relevant information for individual trials can be found on each vaccine study listed here. All trials are conducted by our clinical research team including specialists in infectious disease and internal medicine.
Founded in 1998, we are a multi-specialty clinical research organization specializing in Phase I-IV industry-sponsored trials. We excel in rapid recruitment, enrollment, and randomization of both healthy and disease-specific patient populations across diverse therapeutic areas, with a strong focus on early-phase development. Our experienced medical team ensures high-quality data, earning recognition from sponsors for top- tier enrollment and performance. In response to industry demand, we successfully pivoted to COVID-19 research, enrolling symptomatic patients in phase I-III studies and earning selection as a sentinel site for an FDA-submitted antibody trial. Our adaptability, expertise, and commitment to excellence make us a trusted partner in clinical research.
Our facility upholds the highest standards in equipment reliability, ensuring precision, compliance, and patient safety in every study.
Cutting-Edge Cellular Processing for Precision Research
Our facility is equipped with expert-driven technology to ensure high-yield, high-viability PBMC isolation for immunology, oncology, infectious disease, and vaccine research.
Trusted by Leading sponsors, our validated methodologies align with the stringent standards of major pharmaceutical and biotech companies.
Phone: 256-236-0055 Ext. 102
Email: pinnacle@pinnacletrials.com
Social:
Schedule a Meeting